Objective-Atherosclerosis is associated with immune responses to oxidized low-density lipoprotein (oxLDL). The presence of activated macrophages and T cells in lesions suggests that cell-mediated immune reactions are taking place during the disease process. However, the role of specific immune responses has remained unclear. We have previously shown that transfer of CD4 ϩ T cells from apolipoprotein E knockout mice (apoE Ϫ/Ϫ ) into immunodeficient apoE
R esearch over the last decades has identified immune mechanisms as pathogenically important in atherosclerosis. 1,2 T lymphocytes and macrophages are present in lesions throughout the development of disease, both in man and experimental models. [3] [4] [5] [6] Most of the T cells in the lesions are CD4
ϩ TCRab ϩ T cells expressing activation markers such as human leukocyte antigen-DR (HLA-DR) and interferon-␥ (IFN-␥). 3, 4, [7] [8] [9] The expression of major histocompatibility complex (MHC) class II molecules such as HLA-DR on activated macrophages and activated T cells adjacent to these macrophages in the lesions strongly suggests that cellmediated immune reactions are taking place in atherosclerosis.
A series of investigations have suggested modified low density lipoproteins (LDLs) as autoantigens in atherosclerosis. 10 LDL accumulates in lesions, where it is modified by oxidative and enzymatic processes. [11] [12] [13] [14] [15] Circulating autoantibodies to epitopes of oxidized LDL (oxLDL) have been detected in patients and experimental animals with atherosclerosis, 13, 16 and antibodies isolated from atherosclerotic lesions recognize oxLDL. 17 Macrophages can take up, process, and present neoantigens such as oxLDL to CD4ϩ T cells, eliciting cellular immune responses. 18 Indeed, Ϸ10% of the CD4ϩ T cells cloned from human lesions recognize oxLDL in an MHC class II-dependent manner. 9 The apolipoprotein E knockout (apoE Ϫ/Ϫ ) mouse is a useful model of human disease because it develops severe hypercholesterolemia and spontaneous atherosclerosis. 19, 20 In this model, a local immune response dominated by CD4ϩ T cells occurs in all phases of atherosclerosis. 5, 21 T cells from immune organs of apoE Ϫ/Ϫ mice exhibit strong reactivity toward oxLDL. 22 In addition, high titers of circulating autoantibodies to oxLDL are detected in this model. 23 However, the role of the T-cell immune response to modified LDL in the disease process has remained unclear.
To study the role of adaptive immunity in atherosclerosis, we generated an immunodeficient apoE Ϫ/Ϫ scid/scid mouse by crossing apoE Ϫ/Ϫ mice with the scid/scid strain, which lacks T and B cells. 24 We reported previously that transfer of CD4 ϩ T cells from aged apoE Ϫ/Ϫ mice into immunodeficient apoE Ϫ/Ϫ scid/scid mice accelerates the progression of atherosclerosis. 24 To determine whether this effect is dependent on specific disease-associated antigens, CD4 ϩ T cells from mice immunized with oxLDL were transferred into apoE Ϫ/Ϫ scid/ scid mice. Controls included CD4 ϩ T cells from mice immunized with a nonrelevant antigen, keyhole limpet hemocyanin (KLH), or with incomplete Freund's adjuvant (IFA) alone, as well as untouched mice. Our results demonstrate an important role for the oxLDL-specific T-cell response as an accelerating factor in atherosclerosis.
Methods
Animals, Diets, and Serum Analysis C57BL/6J mice obtained from Taconic Europe, Ry Denmark, and apoE Ϫ/Ϫ scid/scid mice on the C57BL/6J background were generated in our laboratory, 24 kept under sterile conditions, and fed standard mouse chow. All experiments were approved by the local ethics committee. The apoE Ϫ/Ϫ scid/scid mice were injected intravenously with CD4
ϩ T cells at 7 weeks of age and euthanized at 16 weeks. To exclude a potential "leakage" (ie, appearance of immune cells), which has been reported in aged scid/scid animals, we assessed the frequency of immunocompetent cells by flow cytometry. Splenocytes were stained with fluorescein isothiocyanate-conjugated rat anti-CD3, phycoerythrin-conjugated rat anti-CD8, phycoerythrinconjugated rat anti-CD19, and CyChrome conjugated rat anti-CD4. All antibodies were from PharMingen. Blood was obtained by heart puncture at euthanization and allowed to clot. Sera were centrifuged at 14 000g for 20 minutes to remove chylomicrons. The serum IFN-␥, interleukin-4 (IL-4), and IL-5 levels were analyzed by sandwich ELISA with OptELA antibody sets (PharMingen) and serum cholesterol by the cholesterol oxidase method (Boehringer Mannheim).
Homologous LDL Isolation and Modification
Blood was obtained by heart puncture from 8-to 10-week-old apoE Ϫ/Ϫ mice and pooled into vacuum tubes containing K 2 EDTA. LDL was isolated from plasma by ultracentrifugation through a discontinuous NaCl gradient of 1.020 to 1.063 mg/mL for 20 hours at 4°C in a Beckman L8-80 ultracentrifuge with a 50.3-Ti Beckman fixed-angle rotor. 16, 25 In plasma from apoE Ϫ/Ϫ mouse, this density cutoff may contain chylomicron remnants in addition to LDL. 25, 26 The protein content was determined by the Lowry method, and the LDL preparation with added Na 2 EDTA (1 mg/mL) was sterile filtered, kept at 4°C under N 2 , and used within 2 weeks. Malondialdehyde (MDA) modification of LDL was performed as described previously. 23 
Immunization Protocol and Analysis of Antigen Specificity
At 6 weeks of age, male C57BL/6J donor mice were randomly divided into 3 groups (nϭ40 per group). Two groups were injected peritoneally with either homologous MDA-LDL (100 g protein per mouse) or KLH (Pierce; 100 g protein per mouse) and boosted once after 2 weeks. MDA-LDL and KLH were emulsified with IFA before immunization. The third group was used as donors of naïve T cells.
Splenocytes were obtained on day 5 after the booster. The splenocytes from individual mice were cultured in duplicate in serum-free medium including 1:100 ITSϩPremix (Collaborative Biomedical), 1 mg/mL BSA, 10 mmol/L HEPES, 1 mmol/L Na pyruvate, 1 mmol/L nonessential amino acids, and 50 g/mL gentamicin sulfate (Sigma) after osmotic lyses of red blood cells. These cells were incubated in the absence of or in the presence of titrated amounts of homologous MDA-LDL or KLH for 72 hours. The incubation was followed by overnight incorporating with 3H-thymidine for the assay of cell proliferation. To quantify the T-cell cytokines secreted by the splenocytes, supernatants harvested 72 hours after incubation were measured using a Th1/Th2 Cytokine CBA Kit (BD Biosciences) according to manufacturer instruction.
Negative Selection and Adoptive Transfer of CD4

؉
T Cells
Splenocytes from immunized mice were pooled and incubated in plastic dishes for 90 minutes at 37°C after red blood cells were lysed. Nonadherent cells were incubated at 4°C for 30 minutes with biotin-conjugated rat-anti-mouse-CD19/CD22, anti-mouse-CD8, anti-mouse-Mac-1 (CD11b), and anti-mouse-c-kit (CD117) to remove potential peripheral stem cells. This was followed by addition of streptavidin-coated microbeads and elimination on MiniMACS columns. The purified cells were Ͼ95% viable and contained Ͼ99% CD3 ϩ CD4 ϩ T cells and Ͻ1% CD22 ϩ B cells as judged by flow cytometry. At 7 weeks of age, female apoE Ϫ/Ϫ scid/scid mice were randomly divided into 4 groups (nϭ5 to 9 per group) as follows: (1) transfer of CD4ϩ T cells from mice immunized with MDA-LDL ( MDA-LDL CD4 ϩ ), (2) transfer of CD4ϩ T cells from KLH-immunized mice ( KLH CD4 ϩ ), (3) transfer of CD4 ϩ T cells from unimmunized mice ( naïve CD4 ϩ ), and (4) untouched controls. Every mouse received 12ϫ10 6 CD4 ϩ T cells via the tail vein. All recipients were euthanized at 16 weeks of age (ie, 9 weeks after cell transfer).
Quantitation of Plaque Size, Cellular Components, and Markers of Immune/Inflammatory Activation
Recipient apoE
Ϫ/Ϫ scid/scid mice were euthanized in a CO 2 chamber at 16 weeks of age and perfused transcardially with PBS. The heart was dissected out and the tissue segment from sinus aorticus to the lower tips of the right and left atria was isolated, snap-frozen in liquid nitrogen, and embedded with O.C.T. (Tissue-Tek) compound. The tissue was sectioned at a thickness of 10 m. For morphometric analysis, 5 sections starting at the level of the aortic valves were chosen at 100-m intervals. Sections were stained with Oil Red O and counterstained with hematoxylin. The size of the plaque was measured with Leica Q500MC image analysis software. The mean value of plaque cross-section areas from 5 sections was used to estimate the extent of atherosclerosis. 24 To evaluate T-cell infiltration and inflammatory molecule expression in the plaques, immunohistochemistry staining was performed by using monoclonal biotin-conjugated rat anti-CD4, anti-I-A b (MHC class II) and anti-vascular cell adhesion molecule-1 (VCAM-1) followed by avidin-horseradish peroxidase. 24 
Statistics
Results are expressed as meanϮSEM. Data were analyzed by the Mann-Whitney test. The significance level was set at PϽ0.05.
Results
Induction of Antigen-Specific T Cells
The adoptive transfer experiment was performed to assess the role of specific antigen in the disease-aggravating action of 
CD4
ϩ T cells on atherosclerosis. Six-week-old C57BL/6J (denoted B6) rather than apoE Ϫ/Ϫ mice were chosen as donors because their T cells are largely näive, whereas the autoimmune process starts early in apoE Ϫ/Ϫ mice. The experimental design is outlined in Figure 1 . Donor B6 mice were immunized twice with MDA-LDL or the control antigen KLH. To avoid inducing a T-cell response to other antigens (eg, heat shock proteins), IFA rather than complete Freund's adjuvant was used in our immunization protocol. The splenocytes of MDA-LDL-immunized mice showed a dose-dependent proliferation in response to in vitro stimulation with MDA-LDL but not to KLH (Figure 2A and 2B) . Strong systemic IgG responses were registered to the respective antigens ( Figure I , available online at http://atvb.ahajournals.org). T-cell proliferation was accompanied by increased expression of the T-cell cytokines IFN-␥ and IL-2 ( Figure 2C and 2D) . Splenocytes collected from KLH-primed mice exhibited significant proliferation when exposed to KLH but not to MDA-LDL in vitro and was accompanied by increased expression of the T-cell cytokines IFN-␥, IL-2, and IL-5 ( Figure 2B , 2F through 2H). The results of the proliferation assay and the expression pattern of the T-cell cytokines therefore indicated the induction of antigen-specific T cells to the respective antigens used for immunization. No IL-4 production was detected in any of the groups, as is usually the case with B6 mice (data not shown). Robust IL-5 secretion was registered from the KLH-primed T cells when challenged in vitro with KLH ( Figure 2I ). In contrast, IL-5 level did not increase when T cells from MDA-LDL-immunized mice were exposed to their cognate antigen (ie, MDA-LDL; Figure 2I ). Expression of tumor necrosis factor-␣ (TNF-␣) increased in T cells from MDA-LDL-immunized mice in response to in vitro MDA-LDL stimulation ( Figure 2E ), whereas TNF-␣ levels were not significantly changed in KLH-primed group after stimulation with KLH (data not shown). In conclusion, a Th1 response was observed when splenocytes from mice immunized with MDA-LDL were challenged with MDA-LDL in vitro. In contrast, both Th1 and Th2 responses took place in the splenocytes primed with KLH and stimulated in vitro with KLH ( Figure 2I ).
Phenotype of Recipient ApoE
؊/؊ scid/scid Mice At 16 weeks of age, no differences were registered in body weight or serum cholesterol levels between treatment groups (Table ) . No T cells, B cells, or immunoglobulins could be detected in the untouched apoE Ϫ/Ϫ scid/scid mice. As expected, CD4
ϩ T cells but not CD8 ϩ T cells or B cells were found in mice that had received CD4ϩ T cell transfer. There was no significant difference in the number of CD4 ϩ T cells in spleens between the groups that received T cells from different donor groups (Table) . Interestingly, serum concentrations of the Th1 cytokine IFN-␥ were very low both in untouched apoE Ϫ/Ϫ scid/scid mice and in mice receiving either naïve CD4 ϩ or KLH CD4 ϩ T cells but increased significantly in the group transferred with MDA-LDL CD4 ϩ T cells ( Figure 2J ). This may reflect an antigen-specific activation of MDA-LDL specific CD4ϩ cells in vivo. Serum levels of the Th2 cytokines IL-4 and IL-5 were below the detection limit for all groups (data not shown). Figure 3 ). The latter 2 treatment groups did not differ significantly from each other with regard to lesion size but differed from lesion size in untreated mice ( Figure 3 ).
Lesion Development in ApoE
T-Cell Homing and Inflammatory Molecule Expression in the Lesions After Specific T-Cell Transfer
Immunohistochemical analysis showed a strikingly increased infiltration of CD4 ϩ cells into the lesions after MDA-LDL CD4 ϩ T cell transfer ( Figure 4A and B) compared with other treatments. Furthermore, expression of the MHC class II molecule I-A b was increased several-fold in mice receiving MDA-LDL CD4 ϩ T cells ( Figure 4A and 4C) . VCAM-1 expression was significantly increased in the lesions of all apoE Ϫ/Ϫ scid/scid mice that had received CD4ϩ T cells, irrespective of the specificity of the transferred cells ( Figure 4A and 4D) . 
Bodyweight, Serum Lipids, and Cellular Composition in the Spleens
Discussion
The results of this study show, for the first time, that adoptive transfer of cell-mediated immunity to oxLDL accelerates atherosclerosis. Thus, transfer of CD4ϩ T cells from MDA-LDL-immunized mice caused a 3.4-fold increase in lesion size in apoE Ϫ/Ϫ scid/scid animals. This was nearly a doubling of lesion size when compared with the situation in mice receiving CD4 ϩ T cells from mice immunized with another antigen: KLH. This increase was accompanied by systemic elevation of the Th1 cytokine IFN-␥, by increased penetration of CD4 ϩ T cells into lesions, and by augmented expression of (the IFN-␥-inducible) I-A b protein in the lesions, supporting the notion that Th1 cells producing IFN-␥ play an important role in the disease process. The fact that transfer of CD4 cells into immunodeficient mice aggravates the disease is in line with our previous finding that absence of CD4 cells in apoE Ϫ/Ϫ mice leads to reduced atherosclerosis. 26 A proposed mechanism by which the transferred MDA-LDL-specific CD4ϩ T cells promote atherosclerosis was illustrated ( Figure  5 ). It should be noted that the cholesterol levels were not different among the groups, therefore the acceleration of the disease progression was unlikely because of effects on lipid metabolism. In parallel with augmented lesion development, the mice that received MDA-LDL CD4 ϩ T cells showed an increase in the number of CD4 ϩ T cells in lesions. However, the proportion of CD4ϩ T cells in the spleen did not differ between the recipients of MDA-LDL CD4
ϩ T cells and of KLH CD4 ϩ T cells. These findings suggest that the MDA-LDL-specific CD4 ϩ T cells homed to and expanded in the atherosclerotic lesions, where the MDA-LDL antigen accumulates.
A Th1 response to MDA-LDL was registered when splenocytes harvested from the mice immunized with MDA-LDL were challenged with MDA-LDL in vitro. In contrast, Binder et al reported recently that immunization with MDA-LDL induces Th2-biased responses, 27 although complete Freund's adjuvant-containing mycobacteria, which was used in their study, is well known to be more prone to induce Th1 responses than IFA, which we used. 28 The discrepancy between 2 studies may be explained by the different types of adjuvant, the dose of antigen used for the immunization, the number of boost injections, the composition of the culture medium, or the concentration of antigen applied in vitro. Serum-free medium was used in our study because sera used in cell culture contain high levels of LDL, which may obscure any T-cell response to exogenous LDL particles. Importantly, the peak response of the T cells in vitro to MDA-LDL was detected when a low concentration of oxLDL was added to the cultures, whereas a concentration of oxLDL Ͼ20 g/mL was found to induce cytotoxicity. The precise T-cell epitopes in the oxLDL preparations remain to be identified.
Interestingly, transfer of naïve CD4 ϩ or KLH CD4 ϩ T cells resulted in modestly increased lesions with signs of increased inflammatory activity when compared with untouched control apoE Ϫ/Ϫ scid/scid mice. This may reflect the presence in the naïve CD4 ϩ and the KLH CD4 ϩ T cell preparations of a T-cell population with the capacity to recognize modified LDL or other proatherogenic antigens. Such cells would be activated in situ during the course of the disease, respond immunologically, and aggravate disease development. Alternatively, the homeostatic proliferation of cells transferred in an immunodeficient host could accelerate atherosclerosis because of cytokine secretion or other immune interactions.
VCAM-1 is abundantly expressed in atherosclerotic lesions. 29 -31 It can be induced via the nuclear factor B pathway, which is activated by proinflammatory cytokines, endotoxins, and several other stimuli. 32 In the current study, VCAM-1 was induced to approx the same extent, irrespective of the antigenic specificity of transferred T cells. Our findings suggest that VCAM-1 expression reflects vascular inflammation but is less dependent on antigenic specificity than I-A.
Several gene products of activated T cells are likely to be important in atherosclerosis. Numerous studies point to a proatherogenic role of Th1 products such as IFN-␥ and TNF-␣. 1, 4, 33, 34 Not only does IFN-␥ promote antigen presentation by upregulating MHC genes, it also controls scavenger receptor expression as well as cholesterol efflux in macrophages, proliferation, differentiation and collagen production in smooth muscle cells, and hemostatic properties of the endothelium. 1, 35, 36 TNF-␣ released by activated Th1 cells has profound effects on adhesion molecule expression, lipolytic enzymes, and several other phenomena. The cell surface molecule CD40 ligand (CD154) can activate macrophages and vascular cells, which can express CD40; this leads to secretion of proteolytic enzymes, tissue factor, and other important factors in the atherogenic process. 37 Other costimulatory proteins expressed by immune cells include OX40L, a genotype of which was recently found to associate with coronary artery disease in man. 38 All these effector molecules may be involved in the proatherogenic activity of CD4ϩ T cells, but it remains to be determined whether the properties of the activating antigens affect the effector repertoire. At any rate, our results confirm the notion that CD4ϩ T cells are proatherogenic, support the notion that their disease-aggravating activity may be mediated via Th1 effector molecules, and show that antigenic specificity for the disease-associated antigen oxLDL is associated with dramatic proatherogenic activity. This may be because oxLDL accumulates in the lesions, where it provides a strong local stimulus for T-cell activation.
It has been shown that systemic immunization with oxLDL decreases lesion development with significant elevation of IgG antibodies against oxLDL. 25,39 -41 The finding that immunization with MDA-LDL protects from atherosclerosis in immunocompetent apoE Ϫ/Ϫ mice 25,26,39 -41 whereas transfer of CD4ϩ T cells from mice immunized with MDA-LDL into immunodeficient apoE Ϫ/Ϫ mice aggravates disease in this study may appear puzzling. However, the apoE Ϫ/Ϫ scid/scid mice lack both B and T cells. Therefore, any effects of B cells, including antibodyproducing plasma cells derived from them as well as effects of CD8ϩ T cells, were absent in the present transfer study. In addition, the antigen-presenting cells in apoE Ϫ/Ϫ scid/scid are never directly exposed to the antigens in the preparation used for immunization, including adjuvant, precluding a possible development of tolerogenic antigen-presenting cells. Furthermore, any early protective mechanisms induced by the immunization may not be transferred if the transferred cells are isolated as late as 20 days after the immunization. The fact that the immunization-induced atheroprotection remains in the mice lacking CD4 suggests that other cells than CD4ϩ T cells may play an atheroprotective role after immunization. 26 Recent reports also suggest that humoral immune responses may have protective effects on disease development. 10, 42 Because immunization with oxLDL enhances both cellular and humoral immune responses to the atherosclerosis-related antigen, it is possible that some of the mechanisms activated by immunization are deleterious, whereas others are protective. The timing for the induction of such reaction may also relevant. Further studies are necessary to explore how the balance between such protection and aggravation induced by immunization can be controlled.
To summarize, the present data identify by adoptive transfer methodology that oxidatively modified LDL is an autoantigen that promotes atherosclerosis in hypercholesterolemic mice.
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